BREAKING NEWS: CMS Proposes Extension of MU Stage 2 | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

BREAKING NEWS: CMS Proposes Extension of MU Stage 2

December 6, 2013
by Rajiv Leventhal
| Reprints

The Centers for Medicare & Medicaid Services (CMS) has announced that Stage 2 of meaningful use will be extended through 2016, and Stage 3 will begin in 2017 for providers who have completed at least two years in Stage 2, in what is an incredibly significant reverse of position from the agency.

In a CMS statement, Robert Tagalicod, director, Office of E-Health Standards and Services, CMS, and Jacob Reider, M.D., acting national coordinator for health information technology for the Office of the National Coordinator for Health Information Technology (ONC), said the goal of this change is two-fold: first, to allow CMS and ONC to focus efforts on the successful implementation of the enhanced patient engagement, interoperability and health information exchange requirements in Stage 2; and second, to utilize data from Stage 2 participation to inform policy decisions for Stage 3.

The phased approach to program participation helps providers move from creating information in Stage 1, to exchanging health information in Stage 2, to focusing on improved outcomes in Stage 3. "This approach has allowed us to support an aggressive yet smart transition for providers," read the CMS statement.

This new proposed timeline tracks ongoing conversations CMS and ONC have had with providers, consumers, healthcare associations, EHR developers, and other stakeholders in the healthcare industry. This timeline allows for enhanced program analysis of Stage 2 data to inform to the improvements in care delivery outcomes in Stage 3, according to the CMS statement.

Despite many associations pushing for a Stage 2 extension, as recently as two weeks ago at the American Medical Informatics Association Annual Symposium (AIMA), ONC leaders said changes to Stage 2 of meaningful use would be unlikely.

At that time, Jodi Daniel, ONC’s director of the office of policy planning, said, “We have heard from stakeholders about concerns, and we are looking at timelines. I don’t have magic dice to talk about chances of anything. “She added that any change would be up to CMS, not ONC, and for CMS to change the timeline would require a regulatory change.

Healthcare Informatics will keep you updated as more details from this story emerge. 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Healthcare Execs Anticipate High Cost Returns from Predictive Analytics Use

Healthcare executives are dedicating budget to predictive analytics, and are forecasting significant cost savings in return, according to new research from the Illinois-based Society of Actuaries.

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.